Professor Hilary Thomas - Healthcare Businesswomen`s Association

Professor Hilary Thomas
Professor Hilary Thomas
Partner and Clinical Lead – Life Sciences and Healthcare Advisory and Global Centre of Excellence
Hilary qualified in 1984 and pursued a career in oncology from Senior Lecturer at Imperial to Professor of Oncology at the University of
Surrey where she led a basic science research group and was a keen contributor to clinical trials of all Phases as well as a Key
Opinion Leader in breast cancer and gynaecological malignancies. She has published over 80 papers and led research teams in the
HEFC Research Assessment Exercise. She became Medical Director of a Cancer Network until 2004 and then Medical Director of the
Royal Surrey County Hospital. She was an elected member of the General Medical Council from 1994-2003 during which she chaired
the committee on standards and medical ethics and gave evidence to Select Committees of both Houses of Parliament.
Hilary leads our global health proposition, Care System Redesign working across regional health ecosystems to redesign interorganisational patient pathways and shift the provision of care to more appropriate settings.
Hilary is the most senior clinician within our Life Sciences and Health practice – working with the ABPI on their approach to Big Data
and with a devices firm to develop a modular, global service specification for a clinical condition.She also leads on clinical engagement
and clinical service redesign across a range of engagements including whole system transformation programmes across several
health economies to deliver reconfiguration to ensure sustainable aligned services. She leads on telemedicine, e-health and m-health
and interfaces with the Department of Health on the Three Million Lives Campaign on telehealth and telecare. She has been
supporting the National Specialist Commissioning Team with the reconfiguration of paediatric cardiac surgical services since 2010. In
the past year she has overseen nearly 40 quality governance reviews in the NHS and has worked with Monitor to reviews several
aspirant FTs.
Prior to KPMG Hilary was Group Medical Director of Care UK where she led on clinical governance across the Group. She was a
Leadership Associate of the Kings Fund from 2008-10 and taught on the SpRs and NHS Management Trainee programmes
Hilary was a member of the Healthcare for London Clinical Advisory Group from 2007-10.
She has been a Trustee of Breakthrough Breast Cancer since 2007 and Vice Chair since 2008. she is also a Trustee of Imperial
Healthcare Charity.
MA, Cantab
Fellow of the Royal College of Radiologists
Fellow of the Royal College of Physicians
PhD – in the biology of breast cancer
This document is CONFIDENTIAL and its distribution and use are RESTRICTED © 2012 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of
independent member firms affiliated with KPMG International Cooperative (‘KPMG International’), a Swiss entity. All rights reserved.

similar documents